Ed Biotech announced that the implementation period of the company's share repurchase plan has expired, and the implementation of the repurchase has been completed. As of November 9, 2026, the company had repurchased 10.673 million shares through centralized bidding, accounting for 2.74% of the total share capital. The highest transaction price was 22.53 yuan/share, the lowest transaction price was 15.68 yuan/share, and the total transaction amount was 199 million yuan. The repurchase of shares will be used to cancel and reduce the registered capital. During the repurchase period, Forward-looking Investment Co., Ltd., the controlling shareholder of the company, plans to transfer 20% of the shares to Sinopharm Group Science and Technology Innovation Research Institute Co., Ltd. The transaction is currently undergoing internal decision-making procedures within the Sinopharm Group; the five directors and supervisors increased their total shares by 212,200 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.